Top Markets
Coin of the day
Banyan Corp. Banyan Corp.

Banyan Corp.

BNYN
Rank in Stocks #39972
Banyan Corp., operating through its subsidiaries, focuses on franchising... Banyan Corp., operating through its subsidiaries, focuses on franchising chiropractic clinics throughout North America. The company provides extensive support to its franchisees and licensees, including specialized practice development training and assistance tailored for chiropractors. Beyond its franchising activities, Banyan delivers vital diagnostic testing services. A key offering is Nerve Conduction Velocity (NCV) testing, which is administered to patients via healthcare professionals such as doctors and chiropractors. This NCV testing is instrumental in evaluating the transmission of nerve impulses, identifying irregularities within the nervous system, and supplying objective data to substantiate treatment expenses for patients and their insurance providers. Furthermore, Banyan manufactures and markets its proprietary VT3000, an advanced nerve testing system. This system is engineered for the precise diagnosis of neuropathies – conditions affecting the peripheral nerves and spinal regions – alongside nerve irritation and other forms of nervous system damage in patients. Established in 1978, Banyan Corp. maintains its headquarters in Beverly Hills, California.
Share Price
$0.00019
Last synced: 2026-08-12
Market Cap
$286.04K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Banyan Corp. (BNYN)

Category

P/B ratio for Banyan Corp. (BNYN)
P/B ratio as of 2026 TTM: 0
According to Banyan Corp. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Banyan Corp. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors